Loading...
Loading...
Generating destination analysis
Market Cap
$170B
P/E
70
Revenue Growth
+17.0%
Gross Margin
N/A
ROE
N/A
As a large-cap healthcare company trading on the NASDAQ, Intuitive Surgical has established itself, with indirect exposure to artificial intelligence and robotics through its adjacent operations. Robotic surgery pioneer using AI for surgical planning and autonomy. Valued at 70x trailing earnings with a $170B market capitalization, the company demonstrates consistent top-line gains at +17% year-over-year.
Expert analysis and coverage for Intuitive Surgical
Upgrade to CompassFull access to 500+ ratings • $9/month
Price vs 200DMA
DMA Convergence
50 DMA
200 DMA
Broadcom Inc.
Custom AI accelerator (ASIC) designer with VMware cloud software.
Microsoft Corporation
Cloud and AI platform leader with Azure, Copilot, and OpenAI partnership.
Arista Networks
High-speed networking backbone for hyperscale data centers.
Oracle Corporation
Cloud infrastructure provider with OCI GPU clusters for AI training.
Eli Lilly and Company
Pharma giant leading the GLP-1 revolution with Mounjaro and Zepbound weight-loss drugs.
Alnylam Pharmaceuticals
RNA interference therapeutics leader with approved treatments for rare diseases.
CRISPR Therapeutics
Pioneer of CRISPR gene-editing therapy with first approved treatment for sickle cell disease.
Beam Therapeutics
Base editing platform with differentiated gene-editing pipeline.